Boston Scientific : BSX

All Boston Scientific Articles

258 Articles

Douglas A. McIntyre | Nov 29, 2007 at 6:47 PM EST

Bad News For Boston Scientific (BSX) As Abbott (ABT) Moves Closer To Stent Approval

Abbot Labs (ABT) is trying to get into the stent business. The market has been dominated by Boston Scientific (BSX)…

Douglas A. McIntyre | Nov 28, 2007 at 10:18 AM EST

Abbott’s (ABT) Hammers Boston Scientific (BSX)

Boston Scientific (BSX) has been the leader in sales of stents, those little mess tubes that keep arteries open. Recent…

Douglas A. McIntyre | Nov 23, 2007 at 8:33 AM EST

Largest NYSE Short Interest Decreases (Q, GE, TWX, EMC, BSX, PFE)

It is always interesting seeing which groups and which stocks saw the biggest changes in short interest. This list doesn’t…

Douglas A. McIntyre | Nov 12, 2007 at 6:45 AM EST

As Doctors Renew Interest In Stents, Boston Scientific (BSX) May Get A Break

Several studies which showed that stents could cause blood clotting in the heart have done significant damage to the revenue…

Douglas A. McIntyre | Nov 12, 2007 at 4:24 AM EST

Media Digest 11/12/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, BHP Billiton (BHP) will not sell its petroleum division, as had been rumored, to finance a bid…

Douglas A. McIntyre | Nov 5, 2007 at 5:54 AM EST

Boston Scientific (BSX): Saving Itself Through Auctioning Off Pieces

Boston Scientific (BSX) did it shareholders a terrible disservice buy buying Guidant in a bidding war with Johnson & Johnson.…

Douglas A. McIntyre | Oct 21, 2007 at 10:17 AM EDT

For Boston Scientific And JNJ, The Stent Stats Get Worse

"William O’Neill, dean of clinical affairs at University of Miami’sMiller School of Medicine, says stent-patient traffic is beginning topick up…

Douglas A. McIntyre | Oct 19, 2007 at 6:44 AM EDT

Key Earnings Reactions (October 19, 2007)

(AMD) Advanced Micro Devices -$0.71 EPS vs -$0.62 est.(BSX) Boston Scientific $0.20 EPS vs $0.07 guidance.(CAT) Caterpillar $1.40 EPS vs…

Douglas A. McIntyre | Oct 19, 2007 at 6:11 AM EDT

Boston Scientific’s (BSX) Bleak Outlook

The stent business continues to dog Boston Scientific (BSX) numbers. Several studies have shown that the devices can cause blood…

Douglas A. McIntyre | Oct 18, 2007 at 3:22 AM EDT

Media Digest 10/18/2007 Reuters, WSJ, NYTimes, FT,Barron’s

Accoriding to Reuters, Sony (SNE) will launch a cheaper version of its PS3 in the US in hopes of taking…

Douglas A. McIntyre | Oct 17, 2007 at 5:08 AM EDT

The High Lay-Off Economy (BSX)(INTC)(CFC)(HPQ)

Workers in industries that are not doing well usually get laid off. But, it is not a good omen when…

Douglas A. McIntyre | Oct 16, 2007 at 1:03 PM EDT

Boston Scientific (BSX) Tries To Fire Everyone

Will the last one to leave the building please turn out the lights? Boston Scientific (BSX) will apparently ax up…

Douglas A. McIntyre | Oct 11, 2007 at 5:57 AM EDT

As Stent Business Falls Apart, Field Gets More Crowded

Medtronic (MDT) got the FDA to approve its new drug-coated stent called the Endeavor. The agency did have some concerns…

Douglas A. McIntyre | Oct 6, 2007 at 3:10 PM EDT

Medtronic (MDT): The Stent Business Gets Worse

Medtronic (MDT) has decided to get into the stent business, making the little mesh tubes that keep arteries open. It…

Douglas A. McIntyre | Oct 4, 2007 at 5:37 AM EDT

For Boston Scientific (BSX) Stent News Gets More Complex

Stent sales for Boston Scientific (BSX) and Johnson & Johnson (JNJ) have taken a big drop since research began to…

1 … 14 15 16 17 18

Boston Scientific : BSX

All Boston Scientific Articles

Bad News For Boston Scientific (BSX) As Abbott (ABT) Moves Closer To Stent Approval

Abbott’s (ABT) Hammers Boston Scientific (BSX)

Largest NYSE Short Interest Decreases (Q, GE, TWX, EMC, BSX, PFE)

As Doctors Renew Interest In Stents, Boston Scientific (BSX) May Get A Break

Media Digest 11/12/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Boston Scientific (BSX): Saving Itself Through Auctioning Off Pieces

For Boston Scientific And JNJ, The Stent Stats Get Worse

Key Earnings Reactions (October 19, 2007)

Boston Scientific’s (BSX) Bleak Outlook

Media Digest 10/18/2007 Reuters, WSJ, NYTimes, FT,Barron’s

The High Lay-Off Economy (BSX)(INTC)(CFC)(HPQ)

Boston Scientific (BSX) Tries To Fire Everyone

As Stent Business Falls Apart, Field Gets More Crowded

Medtronic (MDT): The Stent Business Gets Worse

For Boston Scientific (BSX) Stent News Gets More Complex

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

China’s Semiconductor Equipment Companies Gain Share Despite U.S. Sanctions

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

Boston Scientific : BSX

All Boston Scientific Articles

Bad News For Boston Scientific (BSX) As Abbott (ABT) Moves Closer To Stent Approval

Abbott’s (ABT) Hammers Boston Scientific (BSX)

Largest NYSE Short Interest Decreases (Q, GE, TWX, EMC, BSX, PFE)

As Doctors Renew Interest In Stents, Boston Scientific (BSX) May Get A Break

Media Digest 11/12/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Boston Scientific (BSX): Saving Itself Through Auctioning Off Pieces

For Boston Scientific And JNJ, The Stent Stats Get Worse

Key Earnings Reactions (October 19, 2007)

Boston Scientific’s (BSX) Bleak Outlook

Media Digest 10/18/2007 Reuters, WSJ, NYTimes, FT,Barron’s

The High Lay-Off Economy (BSX)(INTC)(CFC)(HPQ)

Boston Scientific (BSX) Tries To Fire Everyone

As Stent Business Falls Apart, Field Gets More Crowded

Medtronic (MDT): The Stent Business Gets Worse

For Boston Scientific (BSX) Stent News Gets More Complex

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

China’s Semiconductor Equipment Companies Gain Share Despite U.S. Sanctions

Featured Reads

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026